blog

A Q&A with Co-Chief Operating Officer, Marie-Hélène Raigneau

Liquid-filled capsules can be rapidly developed and tested, moving quickly from R&D to clinic. And scale-up of the manufacturing process for commercialization is straightforward. Read on for more advantages.

2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.

The formulation of an active pharmaceutical ingredient (API) to ensure maximum bioavailability is central to successful drug development. When an API is insoluble or poorly soluble, it will require processing...

The development of pharmaceutical products, in dosage forms that the human body can safely and effectively metabolize, is a challenging undertaking. In this month's blog, we offer insight on the process, and a related podcast featuring our CDMO experts.